This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Share
Stay up to date

Home
Topics
Webinars/Videos
Infographics
Articles
Case Studies
Forum
Faculty
Unblocked
Webinar
Stay up to date

Low-density Lipoprotein Cholesterol Articles

Articles
Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Bétrisey S, Haller ML, Efthimiou O, et al.
Journal:
J Am Heart Assoc

First published: February 7, 2024 DOI: 10.1161/JAHA.123.030714
View
- Share
Articles
Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability
He L, Liu M, Zhuang X, et al.
Journal:
J Am Heart Assoc

First published: January 31, 2024 DOI: 10.1161/JAHA.123.030132
View
- Share
Articles
Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis
Björnson E, Adiels M, Taskinen MR, et al.
Journal:
J Am Coll Cardiol

First published: January 23, 2024 DOI: 10.1016/j.jacc.2023.10.039
View
- Share
Articles
Influence of Repeated Plaque Visualization on Cardiovascular Risk Reduction after 3 years; a randomized controlled trial
Whitmore K, Zhou Z, Magnussen CG, et al.
Journal:
Eur J Prev Cardiol

First published: January 19, 2024 DOI: 10.1093/eurjpc/zwae026
View
- Share
Articles
Exposome in ischaemic heart disease: beyond traditional risk factors
Montone RA, Camilli M, Calvieri C, et al.
Journal:
Eur Heart J

First published: January 18, 2024 DOI: 10.1093/eurheartj/ehae001
View
- Share
Articles
Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial
Nicholls SJ, Nelson AJ, Lincoff AM, et al.
Journal:
JAMA Cardiol

First published: January 17, 2024 DOI: 10.1001/jamacardio.2023.5155
View
- Share
Articles
Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT
Shah NP, McGuire DK, Cannon CP, et al.
Journal:
J Am Heart Assoc

First published: June 22, 2023 DOI: 10.1161/JAHA.122.029593
View
- Share
Articles
Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association
Kirkpatrick CF, Sikand G, Petersen KS, et al.
Journal:
J Clin Lipidol

First published: June 2, 2023 DOI: 10.1016/j.jacl.2023.05.099
View
- Share
Articles
Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial
Ballantyne CM, Ditmarsch M, Kastelein JJ, et al.
Journal:
J Clin Lipidol

First published: May 31, 2023 DOI: 10.1016/j.jacl.2023.05.098
View
- Share
Articles
Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study
Ray KK, Haq I, Bilitou A, et al.
Journal:
Lancet Reg Health Eur

First published: April 5, 2023 DOI: 10.1016/j.lanepe.2023.100624
View
- Share
Articles
Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020
Jacobs JA, Addo DK, Zheutlin AR, et al.
Journal:
JAMA Cardiol

First published: March 22, 2023 DOI: 10.1001/jamacardio.2023.0228
View
- Share
Articles
Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial
Ballantyne CM, Banka P, Mendez G, et al.
Journal:
J Am Coll Cardiol

First published: March 6, 2023 DOI: 10.1016/j.jacc.2023.02.018
View
- Share

1 2

How would you rate this content?

Privacy Policy
Terms of use
Stay up to date
Cookie Preferences
This Knowledge Hub is supported by Novartis.

Low-density Lipoprotein Cholesterol Articles

Articles

Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Bétrisey S, Haller ML, Efthimiou O, et al.

Articles

Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability

He L, Liu M, Zhuang X, et al.

Articles

Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis

Björnson E, Adiels M, Taskinen MR, et al.

Articles

Influence of Repeated Plaque Visualization on Cardiovascular Risk Reduction after 3 years; a randomized controlled trial

Whitmore K, Zhou Z, Magnussen CG, et al.

Articles

Exposome in ischaemic heart disease: beyond traditional risk factors

Montone RA, Camilli M, Calvieri C, et al.

Articles

Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial

Nicholls SJ, Nelson AJ, Lincoff AM, et al.

Articles

Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT

Shah NP, McGuire DK, Cannon CP, et al.

Articles

Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association

Kirkpatrick CF, Sikand G, Petersen KS, et al.

Articles

Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

Ballantyne CM, Ditmarsch M, Kastelein JJ, et al.

Articles

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

Ray KK, Haq I, Bilitou A, et al.

Articles

Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020

Jacobs JA, Addo DK, Zheutlin AR, et al.

Articles

Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial

Ballantyne CM, Banka P, Mendez G, et al.

Articles

Lipid-Lowering Therapy and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Bétrisey S, Haller ML, Efthimiou O, et al.

Share

Articles

Effect of Intensive Lifestyle Intervention on Cardiovascular Risk Factors: Analysis From the Perspective of Long-Term Variability

He L, Liu M, Zhuang X, et al.

Share

Articles

Lipoprotein(a) Is Markedly More Atherogenic Than LDL: An Apolipoprotein B-Based Genetic Analysis

Björnson E, Adiels M, Taskinen MR, et al.

Share

Articles

Influence of Repeated Plaque Visualization on Cardiovascular Risk Reduction after 3 years; a randomized controlled trial

Whitmore K, Zhou Z, Magnussen CG, et al.

Share

Articles

Exposome in ischaemic heart disease: beyond traditional risk factors

Montone RA, Camilli M, Calvieri C, et al.

Share

Articles

Impact of Bempedoic Acid on Total Cardiovascular Events: A Prespecified Analysis of the CLEAR Outcomes Randomized Clinical Trial

Nicholls SJ, Nelson AJ, Lincoff AM, et al.

Share

Articles

Impact of Ezetimibe on New-Onset Diabetes: A Substudy of IMPROVE-IT

Shah NP, McGuire DK, Cannon CP, et al.

Share

Articles

Nutrition interventions for adults with dyslipidemia: A Clinical Perspective from the National Lipid Association

Kirkpatrick CF, Sikand G, Petersen KS, et al.

Share

Articles

Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial

Ballantyne CM, Ditmarsch M, Kastelein JJ, et al.

Share

Articles

Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study

Ray KK, Haq I, Bilitou A, et al.

Share

Articles

Prevalence of Statin Use for Primary Prevention of Atherosclerotic Cardiovascular Disease by Race, Ethnicity, and 10-Year Disease Risk in the US: National Health and Nutrition Examination Surveys, 2013 to March 2020

Jacobs JA, Addo DK, Zheutlin AR, et al.

Share

Articles

Efficacy and safety of the oral PCSK9 inhibitor MK-0616: a phase 2b randomized controlled trial

Ballantyne CM, Banka P, Mendez G, et al.

Share